Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum]

Authors Dahl R, Jadayel D, Alagappan VKT, Chen H, Banerji D

Received 1 November 2013

Accepted for publication 1 November 2013

Published 16 January 2014 Volume 2014:9(1) Pages 85—86

DOI https://doi.org/10.2147/COPD.S56963

Dahl R, Jadayel D, Alagappan VKT, Chen H, Banerji D. Int J Chron Obstruct Pulmon Dis. 2013;8:501–508.

On page 501, note that in the Results section of the Abstract, the sentence "Trough FEV1 at week 4 for QVA149 and IND+GLY was 1.46 L ± 0.02 and 1.46 L ± 0.18, respectively." should read "Trough FEV1 at week 4 for QVA149 and IND+GLY was 1.5 L ± 0.02."

On page 505, note that the sentence "The least squares mean ± standard error (LSM ± SE) trough FEV1 at week 4 for QVA149 and for the free-dose combination of IND+GLY was 1.5 L ± 0.02 and 1.5 L ± 0.18, respectively (Figure 3)." should read "The least squares mean ± standard error (LSM ± SE) trough FEV1 at week 4 for QVA149 and for the free-dose combination of IND+GLY was 1.5 L ± 0.02 (Figure 3)."

On page 505, note that the confidence interval for Figure 3 was incorrect, and the confidence intervals and y-axis for Figure 4 were also incorrect. The full and correct figures are given here.

Read the original article


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Readers of this article also read:

Relationship between linear and nonlinear dynamics of heart rate and impairment of lung function in COPD patients

Mazzuco A, Medeiros WM, Sperling MP, Souza AS, Alencar MC, Arbex FF, Neder JA, Arena R, Borghi-Silva A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1651-1661

Published Date: 17 August 2015

Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients

Ferrari R, Caram LMO, Faganello MM, Sanchez FF, Tanni SE, Godoy I

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1553-1558

Published Date: 6 August 2015

Caregivers’ burden in patients with COPD

Miravitlles M, Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:347-356

Published Date: 12 February 2015

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

Brockwell C, Ampikaipakan S, Sexton DW, Price D, Freeman D, Thomas M, Ali M, Wilson AM

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:715-721

Published Date: 9 July 2014